X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-25 | ACET | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $2.40 | +3,125,000 | 2,930,527 | -1607% | +$7,500,000 | ||||||
2024-01-25 | ACET | Gordon Carl L | Dir, 10% | P - Purchase | $2.40 | +3,125,000 | 2,930,527 | -1607% | +$7,500,000 | ||||||
| M | 2023-09-28 | ACET | Schor Chen | Pres, CEO | S - Sale | $1.39 | -11,000 | 250,654 | -4% | -$15,291 | |||||
| M | 2023-09-28 | ACET | Schor Chen | Pres, CEO | P - Purchase | $1.38 | +11,000 | 250,654 | +5% | +$15,150 | |||||
2023-06-30 | ACET | Dubin Steve | Dir | P - Purchase | $2.40 | +5,000 | 10,900 | +85% | +$12,000 | ||||||
2023-06-27 | ACET | Gordon Carl L | Dir, 10% | P - Purchase | $2.09 | +875,000 | 962,339 | >999% | +$1,828,750 | ||||||
2023-06-27 | ACET | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $2.09 | +875,000 | 962,339 | >999% | +$1,828,750 | ||||||
2023-02-15 | ACET | Healey Don | CTO | S - Sale | $7.57 | -4,533 | 66,568 | -6% | -$34,327 | ||||||
2023-02-10 | ACET | Healey Don | CTO | S - Sale | $7.98 | -10,467 | 71,101 | -13% | -$83,476 | ||||||
2022-11-10 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale | $21.00 | -6,967 | 28,209 | -20% | -$146,307 | ||||||
2022-11-10 | ACET | Schor Chen | Pres, CEO | S - Sale | $20.30 | -39,955 | 144,893 | -22% | -$811,242 | ||||||
2022-11-07 | ACET | Schor Chen | Pres, CEO | S - Sale | $19.05 | -30,000 | 184,848 | -14% | -$571,488 | ||||||
| M | 2022-11-02 | ACET | Schor Chen | Pres, CEO | S - Sale | $18.04 | -25,313 | 214,848 | -11% | -$456,718 | |||||
2022-10-19 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale | $16.27 | -8,067 | 35,176 | -19% | -$131,250 | ||||||
| D | 2022-10-12 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale+OE | $15.40 | -1,646 | 43,243 | -4% | -$25,348 | |||||
2022-09-14 | ACET | Schor Chen | Pres, CEO | S - Sale | $18.00 | -952 | 261,449 | 0% | -$17,136 | ||||||
| M | 2022-09-09 | ACET | Schor Chen | Pres, CEO | S - Sale | $16.80 | -78,412 | 262,401 | -23% | -$1,317,222 | |||||
2022-08-03 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale | $18.00 | -6,968 | 38,967 | -15% | -$125,424 | ||||||
2022-08-01 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale | $16.64 | -6,968 | 45,935 | -13% | -$115,948 | ||||||
2022-07-05 | ACET | Aftab Blake | Chief Scientific Officer | S - Sale | $14.50 | -1,363 | 52,903 | -3% | -$19,764 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |